HF
CATX icon

HRT Financial’s Perspective Therapeutics CATX Stock Holding History

HRT Financial’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,217
Closed -$145K – 2297
2024
Q1 		$145K Buy
12,217
+10,190
+503% +$86.9K ﹤0.01% 1817
2023
Q4 		$8K Sell
2,027
-8,244
-80% -$23.2K ﹤0.01% 2094
2023
Q3 		$28K Buy
+10,271
New +$47.9K ﹤0.01% 2042
2023
Q1 		– Sell
-3,019
Closed -$7K – 2546
2022
Q4 		$7K Buy
+3,019
New +$9.95K ﹤0.01% 2249
2021
Q1 		– Sell
-6,295
Closed -$28K – 2720
2020
Q4 		$28K Buy
6,295
+4,434
+238% +$19.6K ﹤0.01% 1732
2020
Q3 		$10K Buy
+1,861
New +$12.1K ﹤0.01% 1806

Other funds holding CATX

CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial's CATX Position: Q2 2024 in Review

HRT Financial sold out of Perspective Therapeutics (CATX) in Q2 2024, closing a stake of 12,217 shares — an estimated $145K sold.

HRT Financial first reported a position in CATX in Q3 2020 and held it in 6 quarters. The position peaked at $145K in Q1 2024. 105 funds tracked by Wall St. Rank hold CATX as of Q2 2024.

  • HRT Financial reported no remaining Perspective Therapeutics position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 12,217 Perspective Therapeutics shares in Q2 2024, an estimated $145K.
  • HRT Financial first reported a position in Perspective Therapeutics in Q3 2020 and held it in 6 quarters.
  • HRT Financial's Perspective Therapeutics position peaked at $145K in Q1 2024.
  • 105 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.